Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That’s all the cheerleaders can ever post—they never ask REAL, challenging business questions.
Another stock I own ¢elz had that modified ticker ¢elzd right before its R/S. Not sure what specific circumstances cause this type of temporary change (it changed back to the normal ticker shortly after)...
Yep—been waiting on these guys on the business side of the house to get out of their own way for 3 years now. At this point I’m here for observation to learn what NOT to do—and periodic comic relief. Still invested, but waiting for an entity FAR different from the FDA to swoop in...
Would love to see this too
“Hope” is NOT a strategy—take it from someone who’s been lingering here for 3 YEARS waiting for the clowns who run this show to get out of their own way...
Multiple millions of dollars of government-funded contracts here. Perhaps you would have us believe that governments committed millions but didn’t know that the company was a “vaporware” phantasmagoria? Not likely
Does a “dead company” go from .0001 to .03 in a matter of weeks?
What difference does it make when it happened? The same group is “managing” things now that presided over the most impotent and inept effort at “commercialization” imaginable. STILL we have no clear business plan, identified revenue streams, etc. Despite representing a “new age” of medicine, certain business fundamentals are indispensable...
Let’s employ just a PINCH of critical thinking to what we know: Ichim is a principal of both CELZ and TSOI, and both companies are engaged in the stem cell space. Unlike CELZ, however, TSOI has undergone NO R/S—whereas CELZ stuck US with a 1:150. If I didn’t know better, I might suspect that one of these was taking on all the bad liabilities and debts of the other. To be clear, for an apples:apples comparison of PPS, we need to DIVIDE the CELZ PPS by 150 (whereas the TSOI PPS has risen organically—i.e. without being artificially inflated by a R/S): TSOI=.0604
CELZ=.000295
How’s that for an eye-opener?
Take it from me: they have NADA. Companies that DO have something don’t announce a 1:150 R/S less than ONE WEEK after a PR “thanking shareholders for their patience” and declaring that “we delivered.”
I’m hanging around until this becomes profitable, or they close their doors and appear in court—whichever comes LAST
Correct: either they didn’t know what they were doing then or they are lying now. Same “management”...
That’s one of the best-written things about the company that I’ve read—and I’ve read their PRs for over 3 years (many of which have had misspellings and other signs of hasty, amateurish composition). Not too sure they want to highlight CaverStem—with a whopping total of 14 provider sites worldwide after 3 years of “commercialization “...
The same clowns are running this now as ran it into the ground in the last two years. Again, I ask—I DEFY—ANY of them to tell me what is DIFFERENT now, why we should see competence where none could be shown before? Sell something or hold onto it and generate revenues—but DO SOMETHING ALREADY!
TDA does
I once believed that. For 3+ years we’ve been waiting for a clear explanation and exposition of their value. They either refuse to say or are incapable.
I suggest you look at the last 3 years’ worth of data (financial “returns” of “commercialization,” number of docs signing up quarter over quarter, and the STILL absent clear financial plan for specific revenue streams with targets and performance against those targets). THEY are the ones who framed this in terms of “commercialization”: if it takes a business 3+ years to generate commercial revenues (and we STILL do have anything even close to being worth mention), then either their products are worthless or their business strategies stink—or some combination of the two. Despite the 21st-century nature of the science, the BUSINESS side of this is hardly rocket science...
After 3 years, I know—that this is a ridiculous and laughable excuse for a business management approach to a stem cell company. EITHER their science stinks and has no real underlying value, OR their business “minds” are pathetically incapable of communicating that value in a clear and compelling way that the market will understand and react favorably to—OR BOTH. There is no other rational explanation or excuse for what “management” is doing (or NOT doing) at this point.
Massive VOLUME—which often precedes a jump in PPS
I’m from the Jerry Maguire school: SHOW ME THE MONEY—in terms of revenues, profits, PPS, and a robust, clear, and compelling business plan. Consistent with these would be periodic mention of CELZ within publications that cover industry leaders in this space: right now they are essentially a non-entity. Absent these things, it’s all just hollow hype...
That’s what several of us thought 3 YEARS ago: it went to .07 legit (i.e. without the inflationary benefit of a 1:150 R/S), only to tank gradually all the way down to .0002–even as they claimed they were “commercializing” CaverStem: “commerce”= REVENUES—and an enterprising teenager can cut lawns and make what they generated...
This stock is for flippers and game-players—look elsewhere for “investments” (look at the last 3 years for plenty of validation of that claim). Current PPS, split-adjusted for those of us who got DESTROYED by the R/S, is .00034
I didn’t see CMTH/CELZ mentioned anywhere in that article. It’s no longer enough to declare ONESELF to be part of some notional “hot market”: everyone WANTS to be in the championship team photo, but only the REAL players get rings...
Does it not strike you as odd/intriguing that someone bought your 350K shares at .095 when the PPS has been trending under .01 since being placed on the EM?
CMH “sells” patents to CMTH (which has the ticker CELZ). CMTH then generates “revenues” through the sale of what amounts to a syringe kit: early data from 2018 indicates that CMTH makes about $1,200 net per kit—and in nearly 3 years of “commercialization” of this sort, they are now offering CaverStem in a whopping 40 sites worldwide. This, mind you, is their “cash cow”...
That’s been the case for 3 years—and “management’s” ineptitude, indecision, and general ineffectiveness at performing actions to drive shareholder value (as measured by the only metric that matters, PPS) and at communicating ABOUT those activities in a clear and compelling manner certainly hasn’t helped...
Thanks for the education! So does this mean we can buy shares but not sell them?
Well someone better inform TD Ameritrade: they are showing exactly what I said earlier
I don’t know. All I see is “OTC Pink”, 59M shares traded so far today, current PPS at .0079, bid at .0128 and ask at .0165. What’s going on here?
So, if this is back to regular OTC trading activity, why has the Bid been roughly 50% higher than the PPS (to say nothing of the Ask—which is even higher) for two days now?
It’s time to bring an end to the moral bankruptcy (assuming if we can’t actually call it “crime”) of those who play with a stacked deck, loaning money to businesses and then waiting in the shadows to manipulate the closed course “market” that they control.
Said SO well: OVER THE TARGET.
After what several did on Twitter 3 years ago, CELZ got damn lucky they missed this (or did they?):
https://www.thinkadvisor.com/2021/02/26/sec-halts-trading-in-15-firms-due-to-social-media-activity/?amp=1